Skip to content
Home/Companies/Pharma/PharmaZell
PH

PharmaZell

Pharma·Germany·Exited 2020·Held 6yr

PharmaZell is a pharma company, headquartered in Germany.

Entry
2014
Hold
6yr
Exit
2020
Est. EV
–

Who owns PharmaZell?

PharmaZell was owned by Maxburg Capital Partners through Maxburg Beteiligungen (2014 vintage) from 2014 to 2020, exited via Secondary. Across its history, PharmaZell has been through 2 private equity ownership periods, detailed in the timeline below.

Buyer identity available on Pro.

Hand-verified · updated 2026-07-03

Maxburg Capital Partners
Most recent investor
Maxburg Capital Partners
Maxburg Beteiligungen · 2014 · Buyout
2 ownership periods · full history below

Key facts

HQGermany
SectorPharma
StatusAcquired
Key takeaways
  • ·Fully exited in 2020.
  • ·Average hold across 2 realized cycles: 7 years.

Ownership history

2 ownership periods · co-invest detected

Exited
Last exited in 2020 to .
Co-invest · 2 holders · 2013 · 2020
DPE Deutsche Private Equity
DPE Deutsche Private EquityExited 2020
2013 · 2020 · DPE Fund II · 2013 · Buyout
Secondary · to
MOIC
–
Maxburg Capital Partners
Maxburg Capital PartnersExited 2020
2014 · 2020 · Maxburg Beteiligungen · 2014 · Buyout
Secondary · to
MOIC
–

More from Maxburg Beteiligungen

Other portfolio companies in the same fund.

Norafin
Active
IndustrialsGermany· 2016
Safety & Technical Supplies
Active
Business ServicesGermany· 2016
Constantia Flexibles
Exited 2023
IndustrialsAustria· 2015
to
zooplus
Exited 2021
E-commerceGermany· 2014
to

More PE-backed in Pharma

Comparable pharma deals from other GPs.

Delpharm
Active
SocadifFrance
Laboratoires Delbert
Active
SocadifFrance
IRAB
Active
ARCHIMEDSpain· 2026
Biogaran
Active
BC PartnersFrance· 2025
Dec Group
Active
capitonSwitzerland· 2025
Essential Pharma
Active
Penta CapitalUK· 2025
Data refreshed weekly · Sourced from public filings